Recent Advances in the Treatment of Bone Metastases and Primary Bone Tumors: An Up-to-Date Review

Cancers (Basel). 2021 Aug 23;13(16):4229. doi: 10.3390/cancers13164229.

Abstract

In the last decades, the treatment of primary and secondary bone tumors has faced a slow-down in its development, being mainly based on chemotherapy, radiotherapy, and surgical interventions. However, these conventional therapeutic strategies present a series of disadvantages (e.g., multidrug resistance, tumor recurrence, severe side effects, formation of large bone defects), which limit their application and efficacy. In recent years, these procedures were combined with several adjuvant therapies, with different degrees of success. To overcome the drawbacks of current therapies and improve treatment outcomes, other strategies started being investigated, like carrier-mediated drug delivery, bone substitutes for repairing bone defects, and multifunctional scaffolds with bone tissue regeneration and antitumor properties. Thus, this paper aims to present the types of bone tumors and their current treatment approaches, further focusing on the recent advances in new therapeutic alternatives.

Keywords: bone cancers; bone substitutes; bone tumors; drug delivery; targeted therapies; tissue-engineered scaffolds.

Publication types

  • Review